About CRI

Howard B. Schiller

Executive Vice President and Chief Financial Officer
Valeant Pharmaceuticals International, Inc.
Bridgewater, NJ

Howard Schiller joined Valeant in December 2011 and is the Company’s Executive Vice President and Chief Financial Officer. He was appointed to the Board of the Company in September 2012. In January 2011, Mr. Schiller retired from Goldman Sachs after a 24-year career. Howard was the chief operating officer for the Investment Banking Division responsible for the management and strategy of the business. Prior to 2009, he was responsible for the global healthcare, consumer products, retail, industrial, and natural resource businesses in the investment banking division. During 2001 and 2002, Mr. Schiller was responsible for the global mergers and acquisitions business. From 1996 through 2001, Howard was in the Goldman Sachs London office, where he was first responsible for the healthcare and chemical industry group and then as chief operating officer of the investment banking business for Europe, the Middle East, and Africa. During his 24 years at Goldman Sachs, he advised large multinational companies on strategic transactions, financings, restructurings, and leveraged buyouts.

Mr. Schiller is on the New York board of Teach for America and on the board of the Cancer Research Institute. He is also on the business advisory council of the University of Chicago Law School. Mr. Schiller received his B.S. in economics from the Wharton School at the University of Pennsylvania and his J.D. from the University of Chicago Law School.